Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
STAR Protocols|October 6, 2024
Protocol for modeling acquired resistance to targeted therapeutics in adherent and suspension cancer cell lines via in situ resistance assayNancy E Sealover, Jacob M Hughes, Patricia L Theard, et al.Science Signaling|September 16, 2025
Wild-type RAS signaling is an essential therapeutic target in RAS-mutated cancersNancy E Sealover, Bridget A Finniff, Jacob M Hughes, et al.Science Signaling|November 25, 2025
SOS1 inhibition suppresses the emergence of osimertinib resistance to generate a durable response in EGFR-mutant lung cancerBrianna R Daley, Patricia L Theard, Jacob M Hughes, et al.Cancer Research|October 22, 2024
SOS1 Inhibition Enhances the Efficacy of KRASG12C Inhibitors and Delays Resistance in Lung AdenocarcinomaBrianna R Daley, Nancy E Sealover, Bridget A Finniff, et al.Pageof 1